Long-Term Efficacy and Safety of Ublituximab in Relapsing Multiple Sclerosis: Results from 6 Years of ULTIMATE I and II Open-Label

Drug Category: Array
Conference Category: Array
Lead Author: Cree B, et al.
Published Date: 24/09/2025
Download Link: /wp-content/uploads/2025/09/6_Years_OLE.ECTRIMS_2025.Platform.Cree_Final.pdf
Download Text:
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top